Health and Fitness Health and Fitness
Tue, December 21, 2010
[ Tue, Dec 21st 2010 ] - Market Wire
Vertex Provides Update to Ongoing Phase 2 Study E .. aprevir and VX-222 for the Treatment of Hepatitis
[ Tue, Dec 21st 2010 ] - Market Wire
Teva and Takeda Settle Generic ACTOS® and ACTOplus met® Litigation
[ Tue, Dec 21st 2010 ] - Market Wire
Humana Inc. Completes Acquisition of Concentra Inc.
[ Tue, Dec 21st 2010 ] - Market Wire
Enzon Board Authorizes Share Repurchase Program
[ Tue, Dec 21st 2010 ] - Market Wire
Landmark Medtronic CoreValve® U.S. Clinical Trial Begins
[ Tue, Dec 21st 2010 ] - Market Wire
Law Office of Jonathan M. Stein, P.L. Investigate .. y Duty by the Board of Martek Biosciences Corpora
[ Tue, Dec 21st 2010 ] - Market Wire
Kendall Law Group Investigates Martek Biosciences Corporation for Shareholders
[ Tue, Dec 21st 2010 ] - Market Wire
Bernstein Liebhard LLP Announces Investigation of .. uisition of Martek Biosciences Corporation by DSM
[ Tue, Dec 21st 2010 ] - Market Wire
Four Rivers (trading as 'Verta Energy') Receives .. roposed UK Waste-to-Energy Plant to Generate Elec
[ Tue, Dec 21st 2010 ] - Market Wire
Rigrodsky & Long, P.A. Investigates Martek Biosciences Corporation Buyout
[ Tue, Dec 21st 2010 ] - Market Wire
A Letter From the President of Biomagnetics Diagnostics Corp.
[ Tue, Dec 21st 2010 ] - Market Wire
Health Net Federal Services Awarded Department of .. r VA Clinics in Espanola and Las Vegas, New Mexic
[ Tue, Dec 21st 2010 ] - Market Wire
Emeritus Senior Living Receives Best of the Web Award 2011
[ Tue, Dec 21st 2010 ] - Market Wire
Allos Therapeuticsa? Marketing Authorisation Appl .. cepted for Review by European Medicines Agency (E
[ Tue, Dec 21st 2010 ] - Market Wire
IntegraMed® CFO John Hlywak to Retire at Year-End; Appoints Tim Sheehan as Interim-CFO
[ Tue, Dec 21st 2010 ] - Market Wire
Pro-Pharmaceuticals & Mount Sinai School of Medic .. nnounce New Liver Fibrosis Research Collaboration
[ Tue, Dec 21st 2010 ] - Market Wire
Amedisys to Present at the 29th Annual J.P. Morgan Healthcare Conference
[ Tue, Dec 21st 2010 ] - Market Wire
Biogen Idec y Neurimmune suscriben acuerdo para tres programas de enfermedades neurodegenerativas
[ Tue, Dec 21st 2010 ] - Market Wire
Biogen Idec en Neurimmune maken overeenkomst beke .. drie programmaa?s voor neurodegeneratieve ziekten
[ Tue, Dec 21st 2010 ] - Market Wire
Biogen Idec et Neurimmune s'accordent sur trois p .. rammes ciblant les maladies neurod©g©n©ratives
[ Tue, Dec 21st 2010 ] - Market Wire
Biogen Idec und Neurimmune melden Vereinbarung be .. drei Programme fr neurodegenerative Erkrankungen
Mon, December 20, 2010
[ Mon, Dec 20th 2010 ] - Market Wire
Biogen Idec e Neurimmune annunciano l'accordo su .. rogrammi relativi alle malattie neurodegenerative
[ Mon, Dec 20th 2010 ] - Market Wire
Gilead Sciences acquisir Arresto Biosciences per 225 milioni di dollari
[ Mon, Dec 20th 2010 ] - Market Wire
Gilead Sciences erwirbt Arresto Biosciences fr 225 Millionen US-Dollar
[ Mon, Dec 20th 2010 ] - Market Wire
Gilead Sciences verwerft Arresto Biosciences voor US$225 miljoen
[ Mon, Dec 20th 2010 ] - Market Wire
Incyte Announces Positive Top-Line Results from C .. ial of INCB18424 in Myelofibrosis, a Debilitating
[ Mon, Dec 20th 2010 ] - Market Wire
TeamHealth Receives UnitedHealth Group's Apex Award
[ Mon, Dec 20th 2010 ] - Market Wire
Biogen Idec and Neurimmune Announce Agreement on Three Neurodegenerative Disease Programs
[ Mon, Dec 20th 2010 ] - Market Wire
WellCare Names Charles G. Berg Non-Executive Chairman of the Board
[ Mon, Dec 20th 2010 ] - Market Wire
Covidien plc publiceert eerstekwartaalcijfers op 1 februari 2011

Covidien plc publiceert eerstekwartaalcijfers op 1 februari 2011


Published on 2010-12-20 10:40:54 - Market Wire
  Print publication without navigation


DUBLIN--([ BUSINESS WIRE ])--Covidien plc (NYSE: COV) publiceert eerstekwartaalcijfers voordat de beurs opent op 1 februari 2011. Het bedrijf houdt hiervoor een conference call voor beleggers om half drie 's middags Amsterdamse tijd. Toegang tot deze conference call kan worden verkregen via de website van Covidien ([ http://investor.covidien.com ]) of per telefoon (866-700-7101). U draait het vermelde nummer als u vanuit de Verenigde Staten belt en actief wilt deelnemen aan het vragenrondje of als u alleen wilt luisteren. Deelnemers buiten de Verenigde Staten bellen het nummer 617-213-8837. De toegangscode voor alle bellers is 21441069.

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.

Contributing Sources